Comparison of iron supplementation methods for hemodialysis patients
Not Applicable
- Conditions
- end-stage kidney disease
- Registration Number
- JPRN-UMIN000017366
- Lead Sponsor
- Shuuwa General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients complicated with potential diseases causing anemia such as hemorrhagic disease, hematological disease, or carcinoma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in hemoglobin values of before and after the iron supplementation and the frequency of side effect by iron supplementation
- Secondary Outcome Measures
Name Time Method Changes in values of serum iron, transferrin saturation, ferritin, and the amount of administered erythropoiesis-stimulating agents